Waters Revenue 2010-2025 | WAT
Waters annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Waters revenue for the quarter ending June 30, 2025 was $0.771B, a 8.86% increase year-over-year.
- Waters revenue for the twelve months ending June 30, 2025 was $3.046B, a 5.89% increase year-over-year.
- Waters annual revenue for 2024 was $2.958B, a 0.07% increase from 2023.
- Waters annual revenue for 2023 was $2.956B, a 0.52% decline from 2022.
- Waters annual revenue for 2022 was $2.972B, a 6.68% increase from 2021.
| Waters Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,958 |
| 2023 | $2,956 |
| 2022 | $2,972 |
| 2021 | $2,786 |
| 2020 | $2,365 |
| 2019 | $2,407 |
| 2018 | $2,420 |
| 2017 | $2,309 |
| 2016 | $2,167 |
| 2015 | $2,042 |
| 2014 | $1,989 |
| 2013 | $1,904 |
| 2012 | $1,844 |
| 2011 | $1,851 |
| 2010 | $1,643 |
| 2009 | $1,499 |
| Waters Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-06-30 | $771 |
| 2025-03-31 | $662 |
| 2024-12-31 | $873 |
| 2024-09-30 | $740 |
| 2024-06-30 | $709 |
| 2024-03-31 | $637 |
| 2023-12-31 | $819 |
| 2023-09-30 | $712 |
| 2023-06-30 | $741 |
| 2023-03-31 | $685 |
| 2022-12-31 | $859 |
| 2022-09-30 | $709 |
| 2022-06-30 | $714 |
| 2022-03-31 | $691 |
| 2021-12-31 | $836 |
| 2021-09-30 | $659 |
| 2021-06-30 | $682 |
| 2021-03-31 | $609 |
| 2020-12-31 | $787 |
| 2020-09-30 | $594 |
| 2020-06-30 | $520 |
| 2020-03-31 | $465 |
| 2019-12-31 | $716 |
| 2019-09-30 | $577 |
| 2019-06-30 | $599 |
| 2019-03-31 | $514 |
| 2018-12-31 | $715 |
| 2018-09-30 | $578 |
| 2018-06-30 | $596 |
| 2018-03-31 | $531 |
| 2017-12-31 | $687 |
| 2017-09-30 | $566 |
| 2017-06-30 | $558 |
| 2017-03-31 | $498 |
| 2016-12-31 | $629 |
| 2016-09-30 | $527 |
| 2016-06-30 | $537 |
| 2016-03-31 | $475 |
| 2015-12-31 | $587 |
| 2015-09-30 | $501 |
| 2015-06-30 | $495 |
| 2015-03-31 | $460 |
| 2014-12-31 | $584 |
| 2014-09-30 | $493 |
| 2014-06-30 | $482 |
| 2014-03-31 | $431 |
| 2013-12-31 | $565 |
| 2013-09-30 | $457 |
| 2013-06-30 | $451 |
| 2013-03-31 | $430 |
| 2012-12-31 | $522 |
| 2012-09-30 | $450 |
| 2012-06-30 | $451 |
| 2012-03-31 | $420 |
| 2011-12-31 | $521 |
| 2011-09-30 | $455 |
| 2011-06-30 | $448 |
| 2011-03-31 | $428 |
| 2010-12-31 | $484 |
| 2010-09-30 | $401 |
| 2010-06-30 | $391 |
| 2010-03-31 | $368 |
| 2009-12-31 | $429 |
| 2009-09-30 | $374 |
| 2009-06-30 | $363 |
| 2009-03-31 | $333 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.717B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
| Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
| IDEXX Laboratories (IDXX) | United States | $51.765B | 53.87 |
| Edwards Lifesciences (EW) | United States | $47.690B | 31.61 |
| Alcon (ALC) | Switzerland | $39.183B | 26.31 |
| IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
| DexCom (DXCM) | United States | $29.443B | 44.17 |
| Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
| STERIS (STE) | Ireland | $24.108B | 25.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
| Hologic (HOLX) | United States | $14.818B | 16.05 |
| Penumbra (PEN) | United States | $10.595B | 77.40 |
| Globus Medical (GMED) | United States | $8.256B | 19.04 |
| Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
| Masimo (MASI) | United States | $7.657B | 25.77 |
| Teleflex (TFX) | United States | $5.578B | 9.00 |
| Glaukos (GKOS) | United States | $5.538B | 0.00 |
| TransMedics (TMDX) | United States | $3.979B | 60.48 |
| Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
| LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
| Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
| Veracyte (VCYT) | United States | $2.356B | 32.55 |
| PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
| Artivion (AORT) | United States | $2.067B | 104.31 |
| Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.156B | 6.62 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.07 |
| Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.717B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
| AngioDynamics (ANGO) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| RxSight (RXST) | United States | $0.374B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
| Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
| NeuroPace (NPCE) | United States | $0.301B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
| Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
| Neuronetics (STIM) | United States | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |